Studies have found that SDCBP2 expression is increased in patients with acute myeloid leukemia (AML), and downregulating SDCBP2 expression can inhibit the proliferation of AML cells and induce their differentiation (19). Here, SDCBP2 is linked to acute myeloid leukemia.